Skip to main content
. 2018 Jan 1;9(2):256–262. doi: 10.7150/jca.22700

Table 2.

Comparison of selected clinical-pathological characteristics and treatment characteristics in female and male elderly PTMC patients.

Variable Males
N=1,123(23.34%)
Female
N=3,689(76.76%)
P value2
Age at diagnosis 0.790
(mean±standard deviation SD) 71.15±5.13 71.20±5.50
Race 0.012
White 973 (86.64) 3,036 (83.03)
Black 57 (5.08) 259(7.02)
Other1 93 (8.28) 367(9.95)
Marital status <0.001
Married 857 (76.31) 1,960(53.13)
Unmarried 210 (18.70) 1,507(40.85)
Unknown 56 (4.99) 222(6.02)
Insurance status 0.506
Insured 874 (77.83) 2,897(78.53)
Uninsured 3 (0.27) 18(0.49)
Unknown 246 (21.90) 774(20.98)
Surgery 0.330
No surgery 9 (0.80) 20(0.54)
Lobectomy 317 (28.22) 1,001(27.13)
Total thyroidectomy 796(70.88) 2,667(72.30)
Unknown 1 (0.10) 1(0.03)
Radiotherapy <0.001
Yes 287 (25.56) 743(20.14)
No 828 (73.73) 2,892(78.40)
Unknown 8 (0.71) 54(1.46)
TNM stage <0.001
I-II 914 (81.39) 3,260(88.37)
III-IV 178 (15.85) 339(9.19)
Unknown 31 (2.76) 90(2.44)
T stage 0.343
T1-T2 1,041 (92.70) 3,463(93.87)
T3-T4 80 (7.12) 222(6.02)
Tx 2(0.18) 4(0.11)
N stage <0.001
N0 957(85.22) 3,431(93.01)
N1 149(12.27) 195(5.29)
Nx 17(1.51) 63(1.70)
M stage 0.002
M0 1,099(97.86) 3,638(98.62)
M1 12(1.07) 10(0.27)
Mx 12(1.07) 41(1.11)
Grade 0.036
Well differentiated 164(14.60) 529(14.34)
Moderately differentiated 28(2.49) 90(2.44)
Poorly differentiated 5(0.45) 7(0.19)
Undifferentiated 4(0.36) 1(0.03)
Unknown 922(82.10) 3062(83.00)

PTMC, papillary thyroid microcarcinoma. TNM, tumor-node-metastasis.

1Includes American Indian/AK Native, Asian/Pacific Islander.

Tx, primary tumor cannot be assessed.

Nx, regional lymph nodes cannot be assessed.

Mx, distant metastasis cannot be assessed.

2Refers to comparison for the differences in proportions in female and male patients.